PPARGC1A and fatty liver disease: Pgc-1α (PPARγ coactivator 1 α) is known to act on mitochondrial biogenesis and reactive oxygen species (ROS); however, it also plays a modulatory role in cytokine expression, improving insulin resistance and hepatic steatosis [21].